First Live Biologics Batch Successfully Filled! : Nova Laboratories Ltd.

Latest from Nova Laboratories

Keeping you up to date with the very latest from Nova Laboratories. Click on the links below to view the news articles.

21/05/2013 Nova Laboratories will be participating at Phacilitate- Partnering For Vaccine Emerging Markets event held in Berlin 10-11 June 2013.
22/04/2013 Please note our offices will be open over the following days during the May bank Holiday.
22/04/2013 Nova will be exhibiting at this year’s Clinical Pharmacy Congress April 26th – 27th 2013 ExCel, London Please come and visit us on Stand D30
11/03/2013 Nova would like to wish all our customers a very Happy Easter, please click to see our opening hours:
25/02/2013 Nova’s innovative Hydris stabilisation device will be featured on the BBC’s Bang Goes The Theory programme on March 18th at 7:30 on BBC One.
11/02/2013 Sam de Costa, stabilization project manager at Nova Laboratories believes aseptic spray drying is a viable alternative to traditional lyophilisation techniques.
21/01/2013 NEWS BULLETIN - In response to customer requests, Nova are pleased to announce the addition of our full ‘Specials’ product portfolio. This can be found within the Product & Services > Specials Manufacturing section of this site.
09/01/2013 Nova Laboratories were recently visited by the BBC to cover Nova’s exciting stabilisation platform; HydRIS® (Hyperdermic Rehydration Injection System).
05/12/2012 Nova would like wish our customers a Merry Christmas and a Happy New Year! …. For Christmas opening times please click here:
30/11/2012 Nova Laboratories Ltd our proud to announce the launch of it's brand new Xaluprine site for both carers and healthcare professionals
30/11/2012 The European Commission has approved a revised formulation of Xaluprine (mercaptopurine oral suspension) which no longer contains the preservative propyl parabens.
26/10/2012 Despite testing times for the pharma industry, outsourced clinical manufacturers have recently seen a significant increase in business.
20/07/2012 ‘Xaluprine’, a liquid form of childhood leukaemia drug Mercaptopurine, will be distributed to hospital pharmacies across Europe after being granted an exclusive licence as an ‘orphan’ product by the European Commission.
21/05/2012 Nova Laboratories launched equine and canine compounding services at the BSAVA World Congress, strengthening its position as the leading supplier of veterinary reformulations.
19/10/2011 Please note the following arrangements in regards to the Christmas 2011 and New Year 2012 holidays.
08/08/2011 Nova’s management, are pleased that it’s Gassed Isolator technology is featured in the August edition of Cleanroom Technology magazine.
28/07/2011 An oral suspension of leukaemia medicine mercaptopurine has moved a key step closer to the European pharmaceutical market.
04/05/2011 When Leicester Royal Infirmary were looking for a company to supply materials for their ground breaking clinical trial into the treatment of bowel cancer, they turned to Nova...
01/05/2011 Manufacturer Nova Laboratories has pioneered a veterinary compounding and reformulation service within Cascade, due to demand from ‘early adopter’ vets.
20/04/2011 Instantly injectable, thermo-stable vaccines at tropical temperatures have attracted interest from around the world, writes John Seaton, of Nova Bio-Pharma Technologies Ltd.
08/04/2011 Pharma companies should focus on their core skills in their own industry - and let those with the knowledge and expertise gained in specialist areas support them and make a huge difference.
01/03/2011 Vets can offer a better range of medicines and improve cat compliance, thanks to Nova Laboratories’ pioneering compounding and reformulation service.
12/01/2011 I recently interviewed Nova Laboratories’ Commercial & Financial Director John Seaton. 2010 has been a year of significant growth/success for the specials and aseptic manufacturing specialist, especially since the company announced, in mid 2009, its acquisition of the assets of temperature-stable liquid vaccines developer Cambridge Biostability, and a storage facility, providing an extra 1,400 sq. m. of space. John talked about…
21/09/2010 Nova Laboratories was pleased to be asked to contribute to a recent BBC investigation into the rising cost of “Specials” within the NHS.
14/05/2010 Nova’s commercial team have recently returned from a successful trip to BIO 2010.
04/12/2009 Nova confirms that its Non-Sterile Compunding Unit, will once again be open to support its customers between Christmas and New Year.
22/09/2009 Nova Laboratories has today confirmed, that due to an increasing number of enquiries from North America, it has decided to exhibit at BIO International Convention 2010.
13/08/2009 Nova Laboratories Ltd has acquired the assets of Cambridge Biostability Ltd, including the intellectual property for two key technologies, the VitRIS and HydRIS platforms.
24/07/2009 Nova Laboratories has signed a 25 year lease on new premises, providing approximately 1400sq metres of additional space.
01/06/2009 Nova will once again be exhibiting at the 2009 Pharmacy Show.
15/05/2009 Nova is currently preparing its stand for the ICSE Madrid 2009 event, which is being held at Feria de Madrid, Spain on 13-15 October 2009.
29/04/2009 Nova Laboratories recently sent members of its commercial team to the ICSE exhibition in Tokyo.
27/11/2008 Nova has signed a new contract worth in excess of £10m.
27/10/2008 A pharmaceutical product is now commercially available as a pre-filled syringe.
14/10/2008 Nova, happy to meet customers new and old.
03/10/2008 Nova has been promoting its services to industrial customers.
12/09/2008 Nova successfully filled its first batch of live biologics.
23/07/2008 Nova today completed the purchase of an additional building.
18/07/2008 Nova has executed a lease on property adjoining its operations at Martin House.
06/05/2008 Nova listed as a Profit Track 100 company for 2008

First Live Biologics Batch Successfully Filled! 12/09/2008

Nova is pleased to announce that today it successfully filled it first batch of live biologics (a batericaphage), in its new dedicated facility. Although, technically challenging, the product had to be filled and frozen within 24 hours of the bulk being manufactured, the process ran without a hitch. Nova is obviously proud to be one of the few manufacturers capable of performing such work, and looks forward to welcoming new customers for this service.

General Enquiries	Special Enquiries
t: +44 (0)116 223 0100	t: +44 (0)116 223 0099
f: +44 (0)116 223 0101	f: +44 (0)116 223 0120
e: info@novalabs.co.uk	e: sales@novalabs.co.uk